ESC 365 - Proteomic biomarkers and biological mechanisms associated with atrial fibrillation in heart failure patients

ESC Professional Premium Access

Proteomic biomarkers and biological mechanisms associated with atrial fibrillation in heart failure patients

Session: Interactions between atrial fibrillation and heart failure

Topic: Pathophysiology and Mechanisms

Speaker: Mr T. Petersen (Rotterdam, NL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Teun B Petersen

Rotterdam (Netherlands (The))

1 follower

6 more presentations in this session

Assessing stroke and mortality risk in heart failure: the CHA2DS2-VASc score's prognostic value in patients with and without atrial fibrillation - a systematic review and meta analysis

Speaker: Doctor I. Kamel (Dorchester, US)

The efficacy of catheter ablation compared to medical therapy in heart failure patients with concomitant atrial fibrillation: A meta-analysis of randomized controlled trials

Speaker: Doctor M. Ishrak Khan (New York, US)

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Speaker: Mr O. Otero Garcia (Santiago de Compostela, ES)

Presence of Atrial Fibrillation (AF) is a poor prognostic marker in patients with Heart Failure with reduced Ejection Fraction (HFrEF) and Left Bundle Branch Block (LBBB)

Speaker: Doctor S. Deshpande (Pune, IN)

No improvement in atrial arrhythmia rates in patients on baroreflex activation therapy

Speaker: Doctor V. Pham (Los Angeles, US)

Access the full session

Interactions between atrial fibrillation and heart failure

Speakers: Mr T. Petersen, Doctor I. Kamel, Doctor M. Ishrak Khan, Mr O. Otero Garcia, Doctor S. Deshpande...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources